Complications Associated With Ureteroscopic Management of Upper Tract Urothelial Carcinoma.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2021
Historique:
received: 02 07 2020
revised: 07 09 2020
accepted: 17 09 2020
pubmed: 9 10 2020
medline: 4 2 2022
entrez: 8 10 2020
Statut: ppublish

Résumé

To compile and examine safety data from clinical studies of endoscopic management of patients with low-grade upper tract urothelial carcinoma (UTUC) to identify rates and factors associated with reported complications. Ovid Medline and Ovid Medline Daily (with Embase as secondary search) including citations from 1946-2018 were queried using the following terms: ureteroscopy, ureter, catheter, endoscopy, complication, adverse events, morbidity, ablation, laser, upper tract urothelial carcinoma, ureteral stricture, ureteral stenosis, and ureteral injury. Abstracts were reviewed for relevance; diagnostic studies, case studies, and reviews were excluded. Thirty-eight publications (7 prospective, 31 retrospective) representing >1100 patients were identified. Ureteral stricture was the most frequently reported complication (studies; rates) (26/38; 0-27%), with incidence associated with number of procedures and treatment method. Bleeding, infection, and fever were most common with adjuvant treatment (BCG or mitomycin). Serious and fatal complications were rare. Ureteral stricture is the most frequent complication of endoscopic UTUC management but can be managed successfully in most cases. Most complications were minor. Although additional prospective studies are needed, these results support the safety of ureteroscopic management of UTUC in appropriately selected patients.

Identifiants

pubmed: 33031842
pii: S0090-4295(20)31234-6
doi: 10.1016/j.urology.2020.09.036
pii:
doi:

Substances chimiques

BCG Vaccine 0
Mitomycin 50SG953SK6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-95

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Jennifer Linehan (J)

Department of Urology, John Wayne Cancer Institute, Providence St. John's Health Center, Santa Monica, CA.

Mark Schoenberg (M)

Department of Urology, The Montefiore Medical Center & The Albert Einstein College of Medicine, Bronx, NY; UroGen Pharma, New York, NY.

Elyse Seltzer (E)

UroGen Pharma, New York, NY.

Kim Thacker (K)

UroGen Pharma, New York, NY.

Angela B Smith (AB)

Department of Urology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC. Electronic address: angela_smith@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH